Patient Centered Research
The Bateman Horne Center (BHC) is squarely targeted on bringing ME/CFS and Fibromyalgia to the mainstream through patient centered research. And progress is accelerating.
Our powerful combination of an active and specialized medical center of excellence with an innovative research program allows us to most effectively focus on the discovery of biomarkers. It is biomarkers that will improve diagnosis and treatment and put us on a pathway to a cure.
Patient participation in research is essential to advancing the science and medicine of ME/CFS and Fibromyalgia.
The BHC Biomarker Research Project is currently:
- Identifying infectious agents associated with ME/CFS together with renowned virus-hunter W. Ian Lipkin, MD & Mady Hornig, MD of Columbia University
- Finding genetic determinants of decreased natural killer cell function by studying families with ME/CFS together with Drs. Dorothy Hudig & Isabel Barao, University of Nevada, Reno
- Validating potential ME/CFS diagnostic cytokine patterns with Drs. Michael Houghton & Abdolamir Landi, University of Alberta
- Applying comprehensive immunogenomics to identify immune signatures to use as predictive biomarkers with Dr. Derya Unutmaz, the Jackson Laboratory of Genomic Medicine
In addition to this important biomarker research, BHC is also collaborating as a key partner on a number of grants that have been awarded or submitted to the National Institutes of Health including one for FM and four for ME/CFS.
Currently, BHC research participants are involved in four Fibromyalgia clinical trials including one for young FM patients.